Abstract
Background
The objective of the study was to investigate whether combined treatment with photodynamic therapy (PDT) and triamcinolone acetonide intravitreally applied is superior to PDT alone in eyes with retinal angiomatous proliferation (RAP).
Methods
Between July 2004 and June 2005 eyes with RAP in age-related macular degeneration were included in a prospective study and were treated with 4 mg of triamcinolone acetonide followed by PDT (group 1). Eyes with RAP treated with PDT alone before June 2004 were retrospectively reviewed (group 2). Distance visual acuity (VA) with Early Treatment Diabetic Retinopathy Study (ETDRS) charts, greatest diameter of the lesion (measured by fluorescein angiography), and retinal thickness (measured by optical coherence tomography) were performed at baseline and at 6 weeks, 3 months, 6 months and 12 months thereafter.
Results
Fifty-eight eyes in 58 patients were included: 27 eyes in the combined treatment group and 31 eyes in the PDT monotherapy group. The groups were comparable with regard to age, gender and RAP stage. VA decreased from 65.6 to 52.0 and from 60.7 to 44.0 letters, and lesion size increased from 3.2 mm to 3.5 mm and from 3.3 mm to 3.5 mm in the combined and monotherapy groups respectively. There was a trend towards a better outcome in the combined group. Significantly (p = 0.01) fewer complications occurred in the combined group (22.2%) than in the monotherapy group (54.8%).
Conclusion
No significant differences could be found in the time course of distance VA, retinal thickness, and lesion size between the PDT monotherapy group and the combined PDT and IVTA group. However, significantly fewer complications occurred in the combined treatment group. New therapeutic strategies might be required in RAP lesions, probably including therapy with anti-angiogenic agents.
Similar content being viewed by others
References
Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O (2006) Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization one-year results of a randomized study. Ophthalmology 113:2243–2250
Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 141:638–645
Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H, Povelka M, Frohner U, Kruger A, Hilgers RD, Krugluger W (2002) Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol 133:215–225
Borrillo JL, Sivalingam A, Martidis A, Federman JL (2003) Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121:558–561
Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C (2004) Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138:1077–1079
Bottoni F, Romano M, Massacesi A, Bergamini F (2006) Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244:1528–1533
Bressler NM (2002) Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 133:168–169
Chan WM, Lai TY, Wong AL, Tong JP, Liu DT, Lam DS (2006) Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study. Br J Ophthalmol 90:337–341
Chandler DB, Rozakis G, de Juan E Jr, Machemer R (1985) The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy. Am J Ophthalmol 99:686–690
Ciulla TA, Criswell MH, Danis RP, Hill TE (2001) Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 119:399–404
Dhalla MS, Blinder KJ, Tewari A, Hariprasad SM, Apte RS (2006) Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 14:752–754
Ergun E, Maar N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M (2006) Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. Am J Ophthalmol 142:10–16
Ferris F, Kassoff A, Bresnick G et al (1982) New visual acuity charts for clinical research. Am J Ophthalmol 94:91–96
Fossarello M, Peiretti E, Zucca I, Serra A (2004) Unfavorable effect of photodynamic therapy for late subretinal neovascularization with chorioretinal anastomoses associated with idiopathic multiple serous detachments of the retinal pigment epithelium. Eur J Ophthalmol 14:568–571
Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA, Yannuzzi LA (2006) Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124:487–492
Green WR, Enger C (1993) Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 100:1519–1535
Jonas JB, Hayler JK, Panda-Jonas S (2000) Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 84(9):1064–1067
Krebs I, Binder S, Stolba U (2006) A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 244(7):863–867
Krebs I, Stolba U, Glittenberg C, Seyeddain O, Benesch T, Binder S (2007) Prognosis of untreated occult choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 245(3):376–384
Kuhn D, Meunier I, Soubrane G, Coscas G (1995) Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 113:1392–1398
Lafaut BA, Aisenbrey S, Vanden Broecke C, Krott R, Jonescu-Cuypers CP, Reynders S, Bartz-Schmidt KU (2001) Clinicopathological correlation of retinal pigment epithelial tears in exudative age related macular degeneration: pretear, tear, and scarred tear. Br J Ophthalmol 85:454–460
Macular Photocoagulation Study Group (1991) Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Arch Ophthalmol 109:1242–1257
Meyer CH, Mennel S, Schmidt JC, Kroll P (2006) Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 90:1207–1208
Michels S, Schmidt-Erfurth U (2003) Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 44:2147–2154
Rogers AH, Martidis A, Greenberg PB, Puliafito CA (2002) Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 134:566–576
Rubin GS, Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic therapy (TAP) study group (2002) Effects of verteporfin therapy on contrast on sensitivity: results from the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation—TAP report No 4. Retina 22:536–544
Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, Michels S, Beckendorf A, Naumann GO (2003) Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4473–4480
Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142:160–162
Slakter JS, Yannuzzi LA, Schneider U et al (2000) Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107:742–753
Sutter FK, Kurz-Levin MM, Fleischhauer J, Bosch MM, Barthelmes D, Helbig H (2006) Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP). Klin Monatsbl Augenheilkd 223:376–378
Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report. Arch Ophthalmol 117(10):1329–1345
Yannuzzi LA, Negrao S, Iida T et al (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416–434
Author information
Authors and Affiliations
Corresponding author
Additional information
None of the authors has a financial interest that is related to the manuscript.
The authors have full control of all primary data and they agree to allow Graefes Archive for Clinical and Experimental Ophthalmology to review their data upon request.
Rights and permissions
About this article
Cite this article
Krebs, I., Krepler, K., Stolba, U. et al. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefes Arch Clin Exp Ophthalmol 246, 237–243 (2008). https://doi.org/10.1007/s00417-007-0651-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-007-0651-0